01:42 PM EDT, 07/02/2024 (MT Newswires) -- Eli Lilly ( LLY ) said Tuesday the US Food and Drug Administration approved Kisunla for the treatment of adults with early symptomatic Alzheimer's disease.
Price: 904.91, Change: -9.46, Percent Change: -1.03